5月13日〈星期五〉18:30-20:00
FRIDAY, MAY 13, 2011
台北君悅大飯店三樓鷺誼廳
Egret & Swallow Room(3F), Grand Hyatt Taipei
PRE-SATELLITE SYMPOSIUM: MULTI-MARKER APPROACH FOR
CARDIO-RENAL SYNDROME
18:30
Opening Remarks………………………………………………………………………...江福田
(Fu-Tien Chiang)
Chair: 陳雲亮(Wan-Leong Chan)
18:40
Cardio-Renal Markers ─ Acute Care Setting……………..………………Alan S. Maisel
Chair: 趙庭興(Ting-Hsin Chao)
19:40
Panel Discussionall
19:55
Closing Remarks………………………………………………………………………….雷孟桓
(Meng-Huan Lei)
-1-
5月13日〈星期五〉18:30-20:00
FRIDAY, MAY 13, 2011
台北遠東國際大飯店地下一樓大都會廳
Metro Suite(3F), Far Eastern Plaza Hotel Taipei
PRE-SATELLITE SYMPOSIUM: BIOMARKERS OF CARDIOVASCULAR
RISK: THE IMPACT OF JUPITER ON CURRENT MANAGEMENT
STRATEGIES
18:30
Opening Remarks……………………………………………………………………….陳亦仁
(Yi-Jen Chen)
Chair: 謝敏雄(Ming-Hsiung Hsieh)
08:50
Biomarkers of Cardiovascular Risk: the Impact of JUPITER on
Current Management Strategies……………………………………………..Jacques Genest
Chair: 黃千玲(Chen-Ling Huang)
09:10
Lipid Management and Statin Selection in DM Population…………………………謝安慈
(An-Tsz Hsieh)
Chair: 劉如濟(Ju-Chi Liu)
09:30
Panel Discussion……………………………………………………………………………… all
09:50
Closing Remarks ……………………………………………………………胡朝榮
(Chaur-Jong Hu)
-2-
5月13日〈星期五〉18:00-20:00
FRIDAY, MAY 13, 2011
台中裕元花園酒店四樓東側包廂
Meeting Room East(4F), Windsor Hotel Taichung
PRE-SATELLITE SYMPOSIUM: ARB ACROSS THE CV CONTINUUM:
CHF, DIABETES & HYPERTENSION
19:00
Opening Remarks………………………………………………………………………...連榮達
(Jong-Da Lian)
Chair: 杜思德(Shih-Te Tu)
19:10
Candesartan: CHARM & CASE-J Studies……………………………………………翁國昌
(Kwo-Chang Ueng)
19:50
Clinical Discussion……………………………………………………………楊得政&黃世忠
(Ter-Cheng Yang & Shih-Chung Huang)
Chair: 蔡正道(Cheng-Tao Tsai)
20:10
Candesartan: Small Difference & Big Impact……………………………Sverre E. Kjeldsen
20:50
Clinical Discussion……………………………………………………………黃建寧&張之光
(Chien-Ning Hwang & Chih-Kuang Chang)
21:20
Closing Remarks………………………………………………………………………….林中生
(Chung-Sheng Lin)
-3-
5月13日〈星期五〉18:30-20:00
FRIDAY, MAY 13, 2011
台北艾美寒舍酒店二樓北河廳
Gemini(2F), Le Meridien
PRE-SATELLITE SYMPOSIUM: PATIENT CENTERED TREATMENT IN
HYPERTENSION WITH CALCIUM CHANNEL BLOCKER
18:30
Opening Remarks………………………………………………………………………...蔡正河
(Cheng-Ho Tsai)
Chair: 侯嘉殷(Charles Jia-Yin Hou)
18:35
The Role of Lipophilic Calcium Channel Blocker in Hypertension Therapy:
From Past to Future…………………………………………………………... Vivencio Barrios
Chair: 陳中和(Chi-Tai Kuo)
18:35
The Role of Lipophilic Calcium Channel Blocker in Hypertension Therapy:
From Past to Future…………………………………...…………………………………趙嘉倫
(Chia-Lun Chao)
Chair: 郭啟泰(Chi-Tai Kuo)
19:25
Panel Discussion………………………………………………………………………………. all
19:55
Closing Remarks………………………………………………………………………….程俊傑
(Jun-Jack Cheng)
-4-
5月14日〈星期六〉08:30-10:00
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
VIP Room (4F)
SYMPOSIUM ON NEW FRONTIERS OF ATRIAL FIBRILLATION
Chair: 郭任遠(Jen-Yuan Kuo)
08:30
New Methods for Atrial Fibrillation Evaluation………………………………………劉言彬
(Yen-Bin Liu)
Chair: 郭啟泰(Chi-Tai Kuo)
08:50
New Drugs for Prevention of Atrial Fibrillation Recurrences………………………翁國昌
(Kwo-Chang Ueng)
Chair: 吳茲睿(Tsu-Juey Wu)
09:10
New Evidences of Antithrombotic Agents for Stroke Prevention in Atrial
Fibrillation………………………………………………………………………………….林立人
(Li-Jen Lin)
Chair: 陳勉成(Mien-Cheng Chen)
09:30
New Advances of Non-pharmacologic Therapy for Atrial Fibrillation……………羅力瑋
(Li-Wei Lo)
Chair: 曾淵如(Yung-Zu Tseng)
09:50
Panel Discussion ……………………………………………………………………………….All
-5-
5月14日〈星期六〉10:30-12:00
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
VIP Room (4F)
SYMPOSIUM OF VENTRICULAR ARRHYTHMIAS ─
RECENT ADVANCES IN MANAGEMENT OF VENTRICULAR
ARRHYTHMIAS
Chair: 陳適安(Shih-Ann Chen)
10:30
Recent Aadvances in Ventricular Arrhythmias of Inherited
Channelopathies……………………………………………………………………Minoru Horie
Chair: 賴文德(Wen-Ter Lai)
10:50
Update on Ventricular Arrhythmias in Structurally Normal Heart:
Insights from Catheter Ablation………………………………………………………...溫明賢
(Ming-Shien Wen)
Chair: 賴凌平(Ling-Ping Lai)
11:10
Update on Ventricular Arrhythmias in Organic Heart Disease:
Changing Role in Catheter Ablation…………………………………………………...林亮宇
(Lian-Yu Lin)
Chair: 邱春旺(Chuen-Wang Chiou)
11:30
Recent Advances in Device Therapy of Ventricular Arrhythmias…………………黃金隆
(Jin-Long Huang)
Chair: 郭啟泰(Chi-Tai Kuo)
11:50
Panel Discussion ………………………………………………………………………………All
-6-
5月14日〈星期六〉08:30-10:00
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
Room201A
RIGHT HEART AND TRICUSPID VALVE DISEASE
Chair: 徐粹烈(Tsui-Lieh Hsu)
08:30
Echocardiography Assessment of Hemodynamics Parameters…………………李道輿
(Tao-Yu Lee)
Chair: 林隆君(Lung-Chun Lin)
08:50
Echocardiography Assessment of Right Ventricle Function and Tricuspid
Valve………………………………………………………………………………………..蔡蕙如
(Huey-Ru Tsai )
Chair: 吳彥雯(Yen-Wen Wu)
09:10
Right Ventricular Function in Adolescents and Adults with Congenital Heart…陳俊安
(Chun-An Chen)
Chair: 秦志輝(Chih-Hui Chin)
09:30
Indication and Surgical Treatment for Tricuspid Regurgitation……………………羅傳堯
(Chwan-Yau Luo)
Chair: 江正文(Cheng-Wen Chiang)
09:50
Question and Discussion……………………………………………………………………….all
-7-
5月14日〈星期六〉10:30-12:00
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
Room 201A
CARDIAC IMAGING ( I ) 【ORAL PRESENTATION】
Chairs: 蔡惟全(Wei-Chuan Tsai)、林少琳(Shoa-Lin Lin)、梁馨月(Hsin-Yueh Liang)
10:30
Diagnostic Value of Segmental Longitudinal Strain by Automated Function
Image in Patients with Intermediate Pretest Probability of Coronary Artery
Disease and Positive Stress Test Result……………………………………………..吳靜芬
(Ching-Fen Wu)
10:45
Reversal of Myocardial Fibrosis in Patients with Unilateral Hhyperaldosteronism
Receiving Adrenalectomy……………………………………………………………….林彥宏
(Yen-Hung Lin)
11:00
Imperfect Efficacy of Myocardial Tissue Doppler for Predicting Left
Ventricular Filling Pressure and the Presence of Severe Pulmonary Edema and
Respiratory Failure in Acute Myocardial Infarction………………………………….王玟樺
(Wen-Hwa Wang)
11:15
Real-Time Three-Dimensional Echocardiography Assessment of Left
Ventricular Remodeling in Patients on Hemodialysis……………………………….楊甯貽
(Ning-I Yang)
11:30
Radiotherapy Provokes Carotid Arteries Inflammation with Increased Uptake
of F-18 Fluorodeoxyglucose Detected by Positron Emission Tomography and
Computed Tomography Scans in Head and Neck Cancer Patients………………王宇澄
(Yu-Chen Wang)
11:45
Epicardial Fat Amount Relating to Insulin Resistance, Metabolic Derangements
and Fatty Liver Disease Independently Contributes to Systemic Inflammation
beyond Body Fat Measure: A Study Validated with Computed Tomography……賴堯暉
(Yau-Huei Lai)
-8-
5月14日〈星期六〉08:30-10:00
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
Room 201BC
HEART FAILURE ─ BASIC RESEARCH
08:30
Opening Remarks ………………………………………………………………………..陳錦澤
(Jin-Jer Chen)
Chairs: 賴文德(Wen-Ter Lai)、王俊傑(Chun-Chieh Wang)
08:35
Innovatively Functional Evaluation: Ventilatory and Cardiac-Cerebral-Muscular
Hemodynamic Responses to Exercise in Patients with Heart Failure…… .……王鐘賢
(Jong-Shyan Wang)
08:55
Cardiac Stem Cell Therapy for Heart Failure………………………………………...李碩粲
(Shuo-Tsan Lee)
09:15
Autologous Bone Marrow Cell Therapy for Cardiac Repair in Pigs………………謝清河
(Patrick C.H. Hsieh)
09:35
The Role of Peroxidome Proliferator-activated Receptor-alpha in
Heart Failure………………………………………………………………………………殷偉賢
(Wei-Hsian Yin)
09:55
Closing Remarks………………………………………………………………………….陳震寰
(Chen-Huan Chen)
-9-
5月14日〈星期六〉10:30-11:55
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
Room 201BC
SETTING UP A SUCCESSFUL HEART FAILURE CENTER
10:30
Opening Remarks ………………………………………………………………………..程文俊
(Wen-Jin Cherng)
Chairs: 翁國昌(Kwo-Chang Ueng)、TBA( )
10:35
The End Stage Heart Failure: Chimei Experience with Case Sharing……………黃崔源
(Tsuei-Yuan Huang)
11:00
The Clinical Application of Telecare in NTUH Heart Failrue Center……………何奕倫
(Yi-Lwun Ho)
11:25
Heart Failure Care Integrating Case Managing and Cardiac Rehabilitation…….王兆弘
(Chao-Hung Wang)
11:50
Closing Remarks…………………………………………………………………………楊茂勳
(Mason Sing Yougn)
- 10 -
5月14日〈星期六〉08:30-10:05
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
Room 201DE
PAH: WHAT CARDIOLOGIST SHOULD KNOW?
08:30
Opening Remarks………………………………………………………………………呂鴻基
(Hung-Chi Lue)
Chair: 林少琳(Shoa-Lin Lin)
08:35
Diagnosis…………………………………………………………………………………..白培英
(Pei-Ying Pai)
Chair: 傅懋洋(Morgan Mao-Young Fu)
08:55
Treatment………………………………………………………………………………….賀萬靖
(Wan-Jing Ho)
Chair: 王國陽(Kuo-Yang Wang)
09:15
Case Report I……………………………………………………………………………..陳柏升
(Po-Sheng Chen)
09:30
Case Report II…………………………………………………………………………….宋思賢
(Shih-Hsien Sung)
Chair: 吳美環(Mei-Hwan Wu)
09:45
Case Report III……………………………………………………………………………謝凱生
(Kai-Sheng Hsieh)
10:00
Closing Remarks…………………………………………………………………………吳美環
(Mei-Hwan Wu)
- 11 -
5月14日〈星期六〉10:30-12:00
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC) ROOM 201 DE
DIFFICULT QUESTIONS IN HT MANAGEMENT
10:30
Opening Remarks………………………………………………………………………...陳志鴻
(Jyh-Hong Chen)
Chair:江晨恩(Chern-En Chiang)
10:35
HT in the Peri-Operative Period………………………………………………………尹彙文
(Huey-Wen Yien)
10:50
Q&A
Chair:許勝雄(Sheng-Hsiung Sheu)
10:55
HT in the Emergency Unit………………………………………………………………黃建華
(Chien-Hua Huang)
11:10
Q&A
Chair:曾春典(Chuen-Den Tseng)
11:15
HT in the Pregnancy……………………………………………………………………..王宗道
(Tzung-Dau Wang)
11:30
Q&A
Chair:程文俊(Wen-Jin Cherng)
11:35
HT in the Dialysis Unit…………………………………………………………………吳麥斯
(Mia-Szu Wu)
11:50
Q&A
11:55
Closing Remarks………………………………………………………………………….林幸榮
(Shing-Jong Lin)
- 12 -
5月14日〈星期六〉08:30-10:00
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
Room 201F
BASIC SCIENCE ( I ) 【ORAL PRESENTATION】
Chairs: 葉宏一(Hung-I Yeh)、王兆弘(Chao-Hung Wang) 、蔡佳醍(Chia-Ti Tsai)
08:30
The Roles of Skp2 and Mitochondrial Malfunction in the Aging-related
Endothelial Progenitor Cell-cycle Retardation in vitro and in vivo………………..吳懿哲
(Yih-Jer Wu)
08:45
Ultrasonic Microbubble Gene Delivery with Plasmids of Different Sizes into
Endothelial Progenitor Cells…………………………………………………………….蘇正煌
(Cheng-Huang Su)
09:00
Atorvastatin, Valsartan and N-acetylcysteine Prevent Cardiac Hypertrophy
and Overexpression of Myocardin in Pressure-overloaded Rat Heart……………邱俊仁
(Chiung-Zuan Chiu)
09:15
Magnesium Lithopermate B Modulates the Signaling Transduction of
Primary Human T Lymphocytes………………………………………………………..鄭正忠
(Cheng-Chung Cheng)
09:30
Electrophysiological Effect of Magnesium Lithospermate B on the Rabbit
Ventricular Myocardium………………………………………………………………….許志雄
(Chih-Hsueng Hsu)
09:45
Synergy between Cyclosporine and Erythropoietin Improves Brain Infarct Size
and Neurological Function in Rats after Ischemic Stroke…………………………鍾文榮
(Wen-Jung Chung)
- 13 -
5月14日〈星期六〉10:30-12:00
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
Room 201F
BASIC SCIENCE ( II ) 【ORAL PRESENTATION】
Chairs: 柯毓麟(Yu-Lin Ko)、陳亦仁(Yi-Jen Chen) 、劉秉彥(Ping-Yen Liu)
10:30
Epicardial/ Subepicardial Cells Contribute Directly to Postnatanl Mammalian
Cardiac Regeneration……………………………………………………………………劉芫宏
(Yuan-Hung Liu)
10:45
Elevated Expression of Connective Tissue Growth Factor in Human Atrial
Fibrillation and Angiotensin II-treated Cardiomyocytes…………………………….柯文欽
(Wen-Chin Ko)
11:00
Effect of Erythropoietin on Level of Circulating Endothelial Progenitor Cells
and Outcome in Patients after Acute Ischemic Stroke……………………………..葉漢根
(Hon-Kan Yip)
11:15
Extracorporeal Shock Wave Therapy Reverses Ischemia-Related Left
Ventricular Dysfunction and Remodeling: Molecular-Cellular and Functional
Assessment……………………………………………………………………………….傅懋洋
(Morgan Mao-Young Fu)
11:30
Factors Related to Atherogenic Potential and Biological Function of
Endothelial Colony-Forming Cells……………………………………………………..劉秉昌
(Ping-Chang Liu)
11:45
Benefit of Combined Extracorporeal Shock Wave and Bone
Marrow-Derived Endothelial Progenitor Cells in Protection against Critical
Limb Ischemia in Rats……………………………………………………………………宋沛勳
(Pei-HsunSung)
- 14 -
5月14日〈星期六〉08:20-10:00
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
South Foyer (3F)
FELLOW CASE PRESENTATION COMPETITION
Chairs: 林俊立(Jiunn-Lee Lin)、林幸榮(Shing-Jong Lin)、
葉森洲(San-Jou Yeh)、劉俊鵬(Chun-Peng Liu)、
黃碧桃(Be-Tau Hwang)、陳瑞雄(Thay-Hsiung Chen)、
李貽恆(Yi-Heng Li)
08:20
Acute Renal Failure Following Direct Renin Inhibitor in a Patient with
Coarctation of Aorta……………………………………………………………………...曾梓維
(Tzu-Wei Tseng)
08:40
Hybrid Therapy for Interrupted Aortic Arch with Aortopulmonary Window in
a Low Birth Weight Infant……………………………………………………………….徐宗正
(Tsung-Cheng Shyu)
09:00
A 28-year-old Woman in the 26th Week of Pregnancy with a 3-day History of
Worsening Palpitation and Dyspnea…………………………………………………..李建霖
(Lee Chien-Lin)
09:20
Pacemaker Syndrome after Mitral Valve Rreplacement : Pacing or
not Pacing for Post-operative Stunned Myocardium………………………………..蔡孟達
(Meng-Ta Tsai)
09:40
A Case of NK/T cell Lymphoma with Cardiac Involvement Presenting with
Electrical Storm after Cardioverter-defibrillator Implantation…………………….黃珊惠
(Shan-Hui Huang)
- 15 -
5月14日〈星期六〉10:30-11:50
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
South Foyer (3F)
YIA FINALISTS PRESENTATION COMPETITION
Referees: 林俊立(Jiunn-Lee Lin)、黃水坤(Shoei K. Stephen Huang)
葉宏一(Hung-I Yeh)、陳震寰(Chen-Huan Chen)
朱凱民(Kai-Min Chu)
10:30
Reduced Number and Impaired Function of Circulating Endothelial
Progenitor Cells in Patients with Abdominal Aortic Aneurysm…………………….宋思賢
(Shih-Hsien Sung)
10:50
Plasma Levels of TNF-α and IL-6 are Associated with Diastolic Heart
Failure through Downregulation of Sarcoplasmic Reticulum Ca 2+ ATPase……李任光
(Jen-Kuang Lee)
11:10
Association Analysis of Single Nucleotide Polymorphisms in Peroxisome
Proliferators-activated Receptor δ Gene with Myocardial Infarction, Infarct Severity and
Metabolic-inflammatory Markers……………………………………………………….蔣俊彥
(Chun-Yen Chiang)
11:30
Significant Association of the Vitamin D Metabolism Gene CYP27A1
Polymorphism with Adipocytokins, Cholesterol Homeostasis and Metabolic
Syndrome in Middle-aged Male………………………………………………………...鄭凱鴻
(Kai-Hung Cheng)
- 16 -
5月14日〈星期六〉08:30-10:00
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC) Room 103
FOUNDAMENTAL CONCEPT & SKILL (I)
Chair: 朱樹勳(Shu-Hsun Chu)
08:30
Mitral Valve………………………………………………………………………………..林芳郁
(Fang-Yue Lin)
Chair:張仁平(Jen-Ping Chang)
09:00
Aortic Valve………………………………………………………………………………..楊友任
(Yu-Jen Yang)
Chair:鄭國琪(Kwok-Kei Cheng)
09:30
Tricuspid Valve……………………………………………………………………………….魏崢
(Jeng Wei)
- 17 -
5月14日〈星期六〉10:30-12:00
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC) Room 103
FOUNDAMENTAL CONCEPT & SKILL (II)
Chair:洪啟仁(Chi-Ren Hung)
10:30
VSD…………………………………………………………………………………………翁仁崇
(Zen-Chung Weng)
Chair:陳益祥(Yih-Sharng Chen)
11:00
TF…………………………………………………………………………………………...張重義
(Chung-I Chang)
Chair:陳瑞雄(Thay-Hsiung Chen)
11:30
Perioperative Critical Care for CHD……………………………………………………詹聖霖
(Sheng-Ling Jan)
- 18 -
5月14日〈星期六〉08:30-10:00
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC) Room 105
CROSS-STRAIT SYMPOSIUM
08:30
Opening Remarks………………………………………..………….. 林幸榮&王建安
(Shing-Jong Lin & Jian-An Wang)
Chair:關瑞錦(Rui-Jin Guan)
08:40
Current Status of ACS Management in China…………………………………….. 王建安
(Jian-An Wang)
Chair:程俊傑(Jun-Jack Cheng)
09:10
Current Status of ACS Management in Taiwan ……………….李 貽 恆
(Yi-Heng Li)
Chair: 林幸榮(Shing-Jong Lin)、邱春光(Chun-Guang Qiu)
09:40
Panel Discussion ……………………………………………………………………All
- 19 -
5月14日〈星期六〉10:30-12:00
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC) Room 105
CROSS-STRAIT SYMPOSIUM
Chair:
10:30
急 性 冠 脉综 合 症抗 栓 ，抗 血 小 板治 疗 (英 文 )…………………………….. 趙迎新
(Zhao Ying-Xin)
Chair:
11:00
2010 年浙江省冠脉介入现状 (英文 )…………….…………………………….孫勇
( )
11:30
Chair:
Panel Discussion ……………………………………………………………………All
09:40
Closing Remarks……………………………………….……………………………TBA
- 20 -
5月14日〈星期六〉12:00-13:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
Banquet Hall(3F)
SATELLITE SYMPOSIUM: ARB & TZD ACROSS THE CV CONTINUUM
12:00
Opening Remarks………………………………………………………………………陳明豐
(Ming-Fong Chen)
Chair: 陳適安(Shih-Ann Chen)
12:05
Candesartan across the CV Continuum in Japan………………………Minoru Horie
Chair: 程俊傑(Jun-Jack Cheng)
12:35
Candesartan: Small Difference & Big Impact……………………………Sverre E. Kjeldsen
Chair: 郭啟泰(Chi-Tai Kuo)
13:05
Clinical Discussion………………………………………………………………………………All
13:25
Closing Remarks…………………………………………………………………………陳志鴻
(Jyh-Hong Chen)
- 21 -
5月14日〈星期六〉12:00-13:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
VIP Room(4F)
SATELLITE SYMPOSIUM: THE IMPORTANCE TO PREVENT
MICROALBUMINURIA ON THE CONTEXT OF CARDIO-RENAL
CONTINUUM
12:10
Opening Remarks ………………………………………………………………………廖朝崧
(Chiau-Suong Liau)
Chair: 郭任遠(Jen-Yuan Kuo)
12:10
New Insight of Renal Protection in Patients with Diabetes/CKD ……………杜思德
(Shih-Te Tu)
Chair: 朱凱民(Kai-Min Chu)
12:35
A ROADMAP from Microalbuminuria Prevention to Additional
Benefit…………………………………………………………………………….Hermann Haller
Chair: 許寬立(Kwan-Lih Hsu)
13:10
Panel Discussion ……………………………………………………………………………All
13:25
Closing Remarks …………………………………………………………………………江福田
(Fu-Tien Chiang)
- 22 -
5月14日〈星期六〉12:00-13:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
South Foyer(3F)
SATELLITE SYMPOSIUM: JUPITER SUB-STUDIES AND THEIR
IMPACT ON CURRENT GUIDELINES
12:00
Opening Remarks………………………………………………………………………葉森洲
(San-Jou Yeh)
Chair: 邱恆正(Herng-Cheng Chiou)
12:10
JUPITER Sub-studies and Their Impact on Current Guidelines………...Jacques Genest
Chair: 柯毓麟(Yu-Lin Ko)
12:50
Panel Discussion………………………………………………………………………………All
13:20
Closing Remarks…………………………………………………………………………林俊立
(Jiunn-Lee Lin)
- 23 -
5月14日〈星期六〉12:00-13:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
North Foyer(3F)
SATELLITE SYMPOSIUM: FURTHER STRATEGIES TOWARD CVD
MANAGEMENT
12:00
Opening Remarks………………………………………………………………………陳志鴻
(Jyh-Hong Chen)
Chair: 吳造中(Chau-Chung Wu)
12:05
What Goal Have We Reached in Treating CKD Patients?……………………………...TBA
( )
Chair: 林幸榮(Shing-Jong Lin)
12:35
LDL, CVD, and CKD: A Journey from 4D to SHARP………………………………江晨恩
(Chern-En Chiang)
Chair: 陳宗瀛(Chung-Yin Chen)
13:05
Panel Discussion ………………….……………………………………………………………All
13:25
Closing Remarks…………………………………………………………………………賴文德
(Wen-Ter Lai)
- 24 -
5月14日〈星期六〉14:00-15:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
VIP Room (4F)
ELECTROPHYSIOLOGY 【ORAL PRESENTATION】
Chairs: 溫明賢(Ming-Shien Wen)、張坤正(Kuan-Cheng Chang)、TAB( )
14:00
Heart Failure Enhanced Pulmonary Vein Arrhythmogenesis and Dysregulated
Sodium and Calcium Homeostasis with Increased Calcium Sparks…………… ...張世霖
(Shih-Lin Chang)
14:15
A Novel Finding: Disparities in the Fibrillatory Electrogram Characteristics in
Patients with Persistent and Long-lasting Atrial Fibrillation………………………..林彥璋
(Yenn-Jiang Lin)
14:30
Ranolazine on ATX-II-induced Pulmonary Vein Arrhythmogenesis: Implications
in Atrial Fibrillation with Long QT Syndrome…………………………………………盧彥佑
(Yen-Yu Lu)
14:45
Differences of Atrial Electrophysiological Properties Between Vagal and
Sympathetic Type Atrial Fibrillations…………………………………………………..羅力瑋
(Li-Wei Lo)
15:00
CHADS2 and CHA2DS2-VASc Scores in the Prediction of Major Adverse
Cardiovascular Events in Patients with Atrial Fibrillation after Catheter Ablation
………………………………………………………………………………………………趙子凡
(Tze-Fan Chao)
15:15
Long-term Follow-up in Patients with Arrhythmogenic Right Ventricular
Cardiomyopathy : Rare Late Occurrence of Malignant Events ..李政 鴻
(Cheng-Hung Li)
- 25 -
5月14日〈星期六〉16:00-17:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
VIP Room (4F)
TOP EP CHALLENGE: LIFE-THREATENING ARRHYTHMIA
Moderator: 張茂松(Mau-Song Chang)
16:00
Electrocardiogram Characteristics in Life Threatening Ventricular
Arrhythmias………………………………………………………………………….Minoru Horie
Moderators: 鄭成泉(Chen-Chuan Cheng)、張坤正(Kuan-Cheng Chang)、
謝敏雄(Ming-Hsiung Hsieh)、蔡佳醍(Chia-Ti Tsai)
16:30
Case I ……………………………………………………………………………………胡瑜峰
(Yu-Feng Hu)
16:45
Case II……………………………………………………………………………………游治節
(Chih-Chieh Yu )
17:00
Case III ……………………………………………………………………………………葉冠宏
(Kuan-Hung Yeh)
17:15
Case IV ……………………………………………………………………………………林維祥
(Wei-Shiang Lin)
- 26 -
5月14日〈星期六〉14:00-15:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
Room 201A
CARDIAC IMAGING (II) & HEART FAILURE
【ORAL PRESENTATION】
Chairs: 溫文才(Wen-Chol Voon)、李愛先(Ai-Hsien Li)、TBA ( )
14:00
Atrial Electromechanical Interval Can Identify Patients with Paroxysmal Atrial
Fibrillation and was Associated with CHADS2 Score and Peak Velocity of
Left Atrial Appendage……………………………………………………………………林美每
(Mei-Mei Lin)
14:15
Age-related Changes in Left Ventricular Strain and Torsion Assessed by
3 Dimensional Ultrasound Speckle Tracking Imaging………………………………李俊毅
(Chun-Yi Li)
14:30
Effects of Preload Reduction on Left Ventricular Function of Uremic
Patients- A Three-dimensional Speckle Tracking Echocardiography Study……吳保宗
(Bao-Tzung Wu)
14:45
The Molecular Mechanism of Diastolic Heart Failure ………………………………吳卓鍇
(Cho-Kai Wu)
15:00
Arterial Wave Reflection is the Most Important Pulsatile Hemodynamic
Prognostic Indicator in Patients Hospitalized due to Acute Heart Failure……….宋思賢
(Shih-Hsien Sung)
15:15
Osteoprotegerin Bone Metabolism and Bone Mineral Density in
Chronic Heart Failure…………………………………………………………………….廖敏村
(Min-Tsun Liao)
- 27 -
5月14日〈星期六〉16:00-17:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
Room 201A
FUTILE MEDICINE
16:00
Opening Remarks………………………………………………………………………黃瑞仁
(Juey-Jen Hwang)
Chair:洪瑞松(Jui-Sung Hung)
16:05
Ethical Issues inTerminal Care in Japan ……………………………………………Gen Ohi
Chair:朱凱民(Kai-Min Chu)
16:35
醫界觀點 ………………………………………………………………………………黃勝堅
(
)
Chair:陳震寰(Chen-Huan Chen)
17:00
法界分析…………………………………………………………………………………張家琦
(
)
17:25
Closing Remarks…………………………………………………………………………謝炎堯
(Yen-Yau Hsieh)
- 28 -
5月14日〈星期六〉14:00-15:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
Room 201BC
ESC/TSOC JOINT SESSION (I)
14:00
Opening Remarks ………………………………………………………………………..陳志鴻
(Jyh-Hong Chen)
Chairs: 賴文德(Wen-Ter Lai)、Ali Oto
14:05
Pathophysiology of Atrial Fibrillation in Heart Failure………………………………陳亦仁
(Yi-Jen Chen)
14:20
Cardiac Mechanical Function in AF with Heart Failure……………………………蔡惟全
(Wei-Chuan Tsai)
14:35
Asian Experience of Device Therapy for AF in Heart Failure……………………王俊傑
(Chung-Chieh Wang)
14:55
European Experience of Device Therapy for AF in Heart Failure …………Robert Hatala
Chair: 曾淵如(Yung-Zu Tseng)
15:15
Panel Disscusion
- 29 -
5月14日〈星期六〉16:00-17:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
Room 201BC
ESC/TSOC JOINT SESSION (II)
Chairs: 陳適安(Shih-Ann Chen)、Riccardo Cappato
16:00
Platelet Function and Anticoagulation Issue in AF with Heart Failure
…………………………………………………………………………………..Riccardo Cappato
16:25
European Guidelines for Treatment of AF in Heart Failure…………………………Ali Oto
16:50
Asian Perspective of AF Management ……………………………………….江晨恩
(Chern-En Chiang)
Chair: 郭啟泰(Chi-Tai Kuo)
17:15
Panel Disscusion
17:25
Closing Remarks………………………….………………………………………………..Ali Oto
- 30 -
5月14日〈星期六〉14:00-15:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
Room 201DE
NOVEL TECHNOLOGY IN CV DIAGNOSIS
14:00
Opening Remarks………………………………………………………………………...李啟明
(Chii-Ming Lee)
Chair: 劉如濟(Ju-Chi Liu)、張釗監(Chao-Chien Chang)
14:05
ST2, from Bench to Bedside…………………………………………………...Dr. Alan Maisel
14:25
Update in Platelet Activity Measurement: From Bench to Bedside……………….劉秉彥
(Ping-Yen Liu)
14:45
New Insights into Development of Vasculature and Heart Failure from
a Novel Yu-3 Gene Predicted from Evolutionary Genomics ………………………游正博
(John Yu)
15:05
Application of Fluorescent Gold Nanocluster in Biomedicine……………………葉宏一
(Hung-I Yeh)
15:25
Closing Remarks…………………………………………………………………………柯毓賢
(Yu-Shien Ko)
- 31 -
5月14日〈星期六〉16:00-17:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
Room 201DE
OFF-TARGET CV EFFECTS OF NON-CV DRUGS
16:00
Opening Remarks ………………………………………………………………………陳志鴻
(Jyh-Hong Chen)
Chair: 江福田(Fu-Tien Chiang)
16:05
NSAID and COX2: What Happened?…………………………………………………江晨恩
(Chern-En Chiang)
16:20
Q&A
Chair: 徐粹烈(Tsui-Lieh Hsu)
16:25
PAH Drugs and CV Effects……………………………………………………………王國陽
(Kuo-Yang Wang)
16:40
Q&A
Chair: 林中生(Chung-Sheng Lin)
16:45
PPAR Agents and CV Events…………………………………………………………陳宗瀛
(Chung-Yin Chen )
17:00
Q&A
Chair: 陳震寰(Chen-Huan Chen)
17:05
Targeted Chemotherapy and CV Events……………………………………………TBA
( )
17:20
Q&A
17:25
Closing Remarks…………………………………………………………………………葉森洲
(San-Jou Yeh)
- 32 -
5月14日〈星期六〉14:00-15:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
Room 201F
CORONARY ARTERY DISEASE ( I )
【ORAL PRESENTATION】
Chairs: 殷偉賢(Wei-Hsian Yin)、羅秉漢(Ping-Han Lo)、康志森(Chih-Sen Kang)
14:00
Clopidogrel Hyporesponsiveness, Interacting with Diabetes Mellitus,
Predicts 2-year Cardiovascular Outcome among Taiwanese Population
Receiving Elective Percutaneous Coronary Intervention…………………………..劉秉彥
(Ping-Yen Liu)
14:150
Comparison of Clinical and Angiographic Results of Endeavor and Endeavor
Resolute stent ------ Single Hospital Experience…………………………………….方慶章
(Ching-Chang Fang)
14:30
The Predictors of Cardiac Allograft Vasculopathy and Its Clinical Outcomes
from a Long-Term Follow up Cohort…………………………………………………..張鴻猷
(Hung-Yu Chang)
14:45
Comparison of the Predictive Value of EuroSCORE, Syntax Score and
Clinical Syntax Score for Outcomes of Patients Undergoing Percutaneous
Coronary Intervention for Unprotected Left Main Coronary Artery Disease……盧澤民
(Tse-Min Lu)
15:00
The New Scoring System (Syntax score + Euro……………………………………黃友君
(You-Chun Huang)
15:15
Evaluation of Coronary Artery Stent Patency by 64-Slice Multi-Detector
Computed Tomography: A Comparison with Conventional Coronary
Angiography and Intravascular Ultrasonography……………………………………洪志凌
(Chi-Ling Hang)
- 33 -
5月14日〈星期六〉16:00-17:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
Room 201F
CORONARY ARTERY DISEASE ( II )
【ORAL PRESENTATION】
Chairs: 廖朝崧(Chiau-Suong Liau)、陳逸忠(I-Chung Chen)、TBA ( )
16:00
Efficacy of STEMI Network in Southern Taiwan- a 3-year Follow Up Study…….郭風裕
(Feng-Yu Kuo)
16:15
Use of the Magnetic Navigation System for Percutaneous Coronary I
ntervention: Initial Results of a Single Center………………………………………..殷偉賢
(Wei-Hsian Yin)
16:30
Clinical Outcome of Emergency Department In-hospital Tele-ECG Triage and
Interventional Cardiologist Activation of the Infarct Team in Acute
ST-Segment-Elevation Myocardial Infarction: Single center
experience…………………………陳冠群
(Kuan-Chun Chen)
16:45
The Intermediate-term Renal Outcomes Following Percutaneous Renal
Artery Stenting in Patients With Severe Baseline Renal Insufficiency…………...張偉俊
(Wei-Chun Chang)
17:00
Increased Rho-Associated Coiled-Coil Containing Protein Kinase (ROCK)
Activity Predicts the Incidence and Severity of Coronary Vasospastic Angina… 洪明銳
(Ming-Jui Hung)
17:15
In-hospital Outcome of Ad hoc Versus Staged Coronary Intervention for
Chronic Total Occlusion Lesions: Single Center Experience………………………林祐賸
(Yu-Sheng Lin)
- 34 -
5月14日〈星期六〉14:00-15:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
South Foyer (3F)
GENERAL CARDIOLOGY ( I ) 【ORAL PRESENTATION】
Chairs: 駱惠銘(Huey-Ming Lo)、顏學偉(Hsueh-Wei Yen)、柯文欽(Wen-Chin Ko)
14:00
An Interplay between Inflammation, Physical Activity and Metabolic
Syndrome among a Geriatric Remote Community in Southern Taiwan………….李柏增
(Po-Tseng Lee)
14:15
Serum Interleukin-18 Can Predict Short-term Mortality for Patients in
the Coronary Care Unit: a Prospective Cohort Study……………………………….陳天心
(Tien-Hsing Chen)
14:30
The hOGG1 Ser326Cys Gene Polymorphism and Risk of Coronary Ectasia in
the Chinese Population………………………………………………………………….林宗憲
(Tsung-Hsien Lin)
14:45
Long-term Outcomes of Femoropopliteal Stent Implantation in Taiwanese
Patients with Peripheral Arterial Occlusive Disease: Single center experience
with 5-year Follow-up…………………………………………………………………….邱威儒
(Wei-Ru Chiou)
15:00
Improvement of Neurocognitive Function after Carotid Artery Stenting in
Patients with Chronic Internal Carotid Artery Occlusion and Objective Cerebral
Ischemia……………………………………………………………………………………林茂欣
(Mao-Shin Lin)
15:15
The Association of Aldosterone and Renin with Carotid Atherosclerosis in
Patients with Coronary Artery Disease………………………………………………..李明義
(Min-Yi Lee)
- 35 -
5月14日〈星期六〉16:00-17:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
South Foyer (3F)
GENERAL CARDIOLOGY ( II ) 【ORAL PRESENTATION】
Chairs: 陳肇文(Jaw-Wen Chen)、蔡良敏(Liang-Miin Tsai)、
王榮添(Eng-Thiam Ong)
16:00
Intensive Surveillance Followed by Assisted Intervention Sustained
the Long-term Limb Salvage in Critical Limb ischemia……………………………..黃玄禮
(Hsuan-Li Huang)
16:15
Activation of Circulating Monocyte Chemoattractant Protein-1 Predicts
Venous Intimal Hyperplasia of Hemodialysis Vascular Access……………………吳志成
(Chih-Cheng Wu)
16:30
Long-term Effect of Statins on the Risk of New-onset Diabetes in Elderly
Taiwanese Hypertensives and Dyslipidemia- A Retrospective Longitudinal
Cohort Study………………………………………………………………………………鍾國屏
(Gwo-Ping Jong)
16:45
Holter ECG-Based T-Wave Alternans Predicts a High Risk of Arrhythmic
Events in Patients with Right Ventricular Outflow Tract-Tachycardia…………….鐘法博
(Fa-Po Chung)
17:00
Time to Revisit the Mechanism for QT Prolongation in Chronic Arsenic
poisoning…………………………………………………………………………………..王致皓
(Chih-Hao Wang)
17:15
Does Coexistent Cerebral Artery StenosisS Impose Higher Events in
Coronary Heart Disease 5-year Follow-up……………………………………………李愛先
(Ai-Hsien Li)
- 36 -
(Ai-Hsien Li)
5月14日〈星期六〉14:00-15:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
Room 103
CARDIOVASCULAR SURGERY& PEDIATRIC CARDIOLOGY
【ORAL PRESENTATION】
Chairs: 邱英世(Ing-Sh Chiu)、王主科(Jou-Kou Wang)、
王水深(Shoei-Shen Wang)、吳俊仁(Jiunn-Ren Wu)
14:00
The Impact of Genetic Syndrome on the Long-term Outcomes in Patients of
Pulmonary Atresia with Ventricular Septal Defect…………………………………陳孟妤
(Meng-Yu Chen)
14:15
Hospital Outcome for Type A Acute Aortic Dissection after Surgical Repair……… 文豪
(Hao Wen)
14:30
Myocardial Deformation Imaging may Help Risk Stratification in
Thalassemia Patients underwent Repeated Transfusion…………………………..陳銘仁
(Ming-Ren Chen)
14:45
Improvement of Neurocognitive Function after Stenting in Asymptomatic
Carotid Artery Stenosis with Objective Ipsilateral Cerebral Ischemia……………陳盈憲
(Ying-Hsien Chen)
15:00
Disease Burden from Pediatric Congenital Heart Disease in Taiwan……………葉樹人
(Shu-Jen Yeh)
15:15
Subclinical Hemolysis in Mechanical Heart Valve Prostheses…………………….張仁平
(Jen-Ping Chang)
- 37 -
5月14日〈星期六〉16:00-17:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC) Room 103
CONTRACEPTION & PREGNANCY IN WOMEN WITH CONGENITAL
HEART DISEASE(CHD)
Chairs: 吳美環(Mei-Hwan Wu)、吳俊明(Jing-Ming Wu)
16:00
Contraception in Women with CHD……………………………………………………林佳慧
(
Lin)
16:25
Risks of Pregnancy & Delivery in Women with CHD…………………………………盧俊維
(Chun-Wei Lu)
16:50
Peripartum Management of Women with CHD………………………………………..李建南
(
Lee)
Chair: 吳俊仁(Jiunn-Ren Wu)
17:15
Q&A
- 38 -
5月14日〈星期六〉14:00-15:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC) Room 105
INTERNATIONAL YI PRESENTATION (I)
14:00
Opening Remarks………………………………………………………………………林幸榮
(Shing-Jong Lin)
Chair: 江正文(Cheng-Wen Chiang)
14:05
Adiponectin And Ischemic Heart Disease (Japan)………………………………Rei Shibata
14:30
Severe Obstructive Sleep Apnea Is Associated with Lower Event Free
Survival Following ST-SEGMENT Elevation Myocardial Infarction:
A Prospective Study (Singapore)……………………………….………………Tee Joo Yeo
14:55
Copeptin:An ultra Early Prognostic Marker of Acute Myocardial Infarction
(Hong Kong)……………………………………………………………………………...Lam Ho
15:20
Q&A
- 39 -
5月14日〈星期六〉16:00-17:30
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC) Room 105
INTERNATIONAL YI PRESENTATION (II)
Chair: 江福田(Fu-Tien Chiang)
16:00
The Relationship Between Serum and Genetic Biomarkers of Inflammation,
Platelet Activation and Endothelial Dysfunction in A Young, Multieyhnic Asian
Population During The Early Phase of Acute Coronary Syndrome-Preliminary
Results (Malaysia)…………………………………………………..…………Ning Zan Khiew
16:25
Generation of Induced Pluripotent Stem Cells from Human Peripheral
Blood: Less Invasive and Clinically Applicable Technique(Japan)……. Shinsuke Yuasa
16:50
(Taiwan) …………………………………………………………………………………..蔡佳醍
(Chia-Ti Tsai)
17:15
Q&A
17:25
Closing Remarks …………………………………………………………………………陳志鴻
(Jyh-Hong Chen)
- 40 -
5月14日〈星期六〉08:30-12:00
SATURDAY, MAY 14, 2011
Demo：Chang Gung Memorial Hospital_Linkou Branch
Lecture：Room 102, TICC
LIVE DEMONSTRATION
08:30
Opening Remarks………………………………………………………………………陳志鴻
(Jyh-Hong Chen)
08:35
Session I
Operators : (Rm. I) Tian-Hai Koh、蔡政廷(Cheng-Ting Tsai)
(Rm. II) Kazuaki Mitsudo、劉世奇(Shih-Chi Liu)、謝宜璋(I-Chang Hsieh)
IVUS Commentator: 顧博明(Po-Ming Ku)
Chairs : 吳炯仁(Chiung-Jen Wu)、李文領(Wen-Lieng Lee)
Commentators : Kazushige Kadota、Aaron Wang、
羅秉漢(Ping-Han Lo)、盧澤民(Tse-Min Lu)、
康志森(Chih-Sen Kang)、林宗憲(Tsung-Hsien Lin)
09:15-09:30
Lecture 1: Experience of Primary PCI for STEMI in Kurashiki Hospital
……………………………………………………..…………………………..Kazushige Kadota
10:15-10:30
Lecture 2: Transradial Cardiovascular Intervention……………………...…….吳炯仁
(Chiung-Jen Wu)
10:30
Session II
Operators : (Rm. I) Tian-Hai Koh、蔡政廷(Cheng-Ting Tsai)
(Rm. II) Jiangtao Yu
IVUS Commentator: 顧博明(Po-Ming Ku)
Chairs : 廖朝崧(Chiau-Suong Liau)、高憲立(Hsien-Li Kao)
Commentators : Kenji Wagatsuma、Sunao Nakamura、
殷偉賢(Wei-Hsian Yin)、李愛先(Ai-Hsien Li)、
洪大川(Ta-Chuan Hung)、陳逸忠(I-Chung Chen)
11:15-11:30
Lecture 3: Bilateral Transradial Approach for Complex CTO Lesions
……………………………………………………………………………...Kenji Wagatsuma
11:30-11:45
Lecture 4: Safety and Efficacy of Left Main Intervention……..……Sunao Nakamura
12:00
Lunch
- 41 -
5月14日〈星期六〉13:30-17:00
SATURDAY, MAY 14, 2011
Demo：Chang Gung Memorial Hospital_Linkou Branch
Lecture：Room 102, TICC
LIVE DEMONSTRATION
13:30
Session III
Operators : (Rm. I) 張其任(Chi-Jen Chang)、Sunao Nakamura、劉世奇(Shih-Chi Liu)
(Rm. II) 李文領(Wen-Lieng Lee)、Yves Louvard、
馬光遠(Guang-Yuan Mar)、Kenji Wagatsuma
IVUS Commentator: 廖智冠(Chih-Kuan Liao)
Chairs : 謝宜璋(I-Chang Hsieh)、王志鴻(Ji-Hung Wang)
Commentators : Tian-Hai Koh、Jiangtao Yu、
黃瑞仁(Juey-Jen Hwang)、王光德(Kuang-Te Wang) 、
柯毓麟(Yu-Lin Ko)
14:15-14:30
Lecture 5: How to Manage DES restenosis…………………………………….Tian-Hai Koh
15:15-15:30
Lecture 6: Drug-eluting Balloon：Insights in Concept and Clinical Application
……………………………………………………………………………………Jiangtao Yu
15:30
Session IV
Operators : (Rm. I or Rm. II) 曹殿萍(Tien-Ping Tsao)
(Rm. II) 李文領(Wen-Lieng Lee)、Yves Louvard、
馬光遠(Guang-Yuan Mar)、Kenji Wagatsuma
IVUS Commentator: 廖智冠(Chih-Kuan Liao)
Chairs : 程俊傑(Jun-Jack Cheng)、李貽恆(Yi-Heng Li)
Commentators : Yves Louvard、陳紹良、潘如濱(Ju-Pin Pan)、
Aaron Wang、方慶章(Ching-Chang Fang)、
邱俊仁(Chiung-Zuan Chiu)、黃啟宏(Chi-Hung Huang)
16:15-16:30
Lecture 7: Advanced Techniques of Bifurcation Stenting in 2011........Yves Louvard
17:10-17:25
Lecture 8: The Modern Approach to infrapopliteal Intervention ……………黃玄禮
(Hsuan-Li Huang)
17:25
Closing Remarks …………………………………………………………………………謝宜璋
(I-Chang Hsieh)
- 42 -
5月14日〈星期六〉17:30-19:00
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
Banquet Hall(3F)
SATELLITE SYMPOSIUM: THE ROLE OF RAAS SYSTEM IN THE
TREATMENT OF METABOLIC SYNDROME
17:30
Opening Remarks………………………………………………………………………黃瑞仁
(Juey-Jen Hwang)
Chair: 李愛先(Ai-Hsien Li)
17:35
New Look at SPC Treatment in Hypertension Patients…………………………….吳懿哲
(Yih-Jer Wu)
Chair: 陳肇文(Jaw-Wen Chen)
18:05
Open Up the Future for Type 2 Diabetes……………………………………………方志元
(Chih-Yuan Fang)
Chair: 傅懋洋(Morgan Mao-Young Fu)
18:35
Panel Discussion………………………………………………………………………………All
18:55
Closing Remarks…………………………………………………………………………許勝雄
(Sheng-Hsiung Sheu)
- 43 -
5月14日〈星期六〉17:30-19:00
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
VIP Room(4F)
SATELLITE SYMPOSIUM: NEW ERA OF ATRIAL FIBRILLATION
MANAGEMENT
17:30
Opening Remarks………………………………………………………………………陳適安
(Shih-Ann Chen)
Chair: 程俊傑(Jun-Jack Cheng)
17:35
Antithrombotic Therapy in Atrial Fibrillation ─ Is Guidelines Working
Out in Real World Setting?……………………………………………………………...林立人
(Li-Jen Lin)
Chair: 林俊立(Jiunn-Lee Lin)
18:05
Dabigatran versus Warfarin in Different Type of Patient ………………Riccardo Cappato
Chair: 葉森洲(San-Jou Yeh)
18:35
Panel Discussion ……………………...………………………………………………………. All
18:55
Closing Remarks…………………………………………………………………………陳志鴻
(Jyh-Hong Chen)
- 44 -
5月14日〈星期六〉17:30-19:00
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
South Foyer(3F)
SATELLITE SYMPOSIUM: RECENT ADVANCE IN THE TREATMENT
OF TYPE 2 DIABETES GLYCEMIC CONTROL AND CARDIOVASCULAR
EVENTS
17:30
Opening Remarks………………………………………………………………………...陳志鴻
(Jyh-Hong Chen)
Chair: 李文領(Wen-Lieng Lee)
17:40
Recent Advance in the Treatment of Type 2 Diabetes Glycemic Control
and Cardiovascular Events …………………………………………………Sophia Zoungas
Chair: 葉振聲(Cheng-Sheng Yeh)
18:20
Panel Discussion ……………………………………………………………………….………All
18:50
Closing Remarks………………………………………………………………………….莊立民
(Li-Min Chuang)
- 45 -
5月14日〈星期六〉17:30-19:00
SATURDAY, MAY 14, 2011
台北國際會議中心(TICC)
North Foyer(3F)
SATELLITE SYMPOSIUM: RESIDUAL RISK REDUCTION IN
ATHEROGENIC DYSLIPIDEMIA
17:30
Opening Remarks………………………………………………………………………王志鴻
(Ji-Hung Wang)
Chair: 王榮添(Eng-Thiam Ong)
17:35
Managing Atherogenic Dyslipidemia ………………………………………….Timothy Davis
Chair: 鍾政達(Cheng-Ta Chung)
18:05
Fibrates and Diabetic Microvascular Complications ……………………………楊偉勛
(Wei-Shiung Yang)
Chair: 陳宗瀛(Chung-Yin Chen)
18:35
Panel Discussion………………………………………………………………………………All
18:55
Closing Remarks…………………………………………………………………………程文俊
(Wen-Jin Cherng)
- 46 -
5月15日〈星期日〉08:30-10:10
SUNDAY, MAY 15, 2011
台北國際會議中心(TICC) Room 201ABC
08:30
President Address………………………………………………………………………..陳志鴻
(Jyh-Hong Chen)
Chair:
08:35
Young Investigator Award Lecture…………………………………………..第一名得獎者
Chair:姜必寧(Benjamin N. Chiang)
08:50
Nong Ting Award Lecture……………………………………………………………….得獎者
特別演講 PLENARY SPEECH
Chair:
09:10
New Design and Development of DES……………………..……….Yves Lovuard
Chair:
09:40
Ethical Issues in Terminal Care in Japan……………….………….……Gen Ohi
10:10
BREAK, VISIT EXHIBITION AREA
- 47 -
5月15日〈星期日〉10:30-11:30
SUNDAY, MAY 15, 2011
台北國際會議中心(TICC) Room 201ABC
特別演講 PLENARY SPEECH
Chair:
10:30
New Advances in the Treatment of Cardiac Arrhythmias ….………………………Ali Oto
Chair:
11:00
XXXXXX ……………………………………………………………………………………Haller?
11:30
Lunch & General Assembly
- 48 -
5月15日〈星期日〉13:00-14:30
SUNDAY, MAY 15, 2011
台北國際會議中心(TICC)
Room 201BC
SATELLITE SYMPOSIUM: THE MANAGEMENT OF ACUTE
CORONARY SYNDROME
13:00
Opening Remarks………………………………………………………………………林幸榮
(Shing-Jong Lin)
Chair: 林幸榮(Shing-Jong Lin)
13:05
Treatment Disparities in Patients with Acute Coronary Syndrome and
Kidney Disease……………………………………………………………Germano Di Sciascio
Chair: 洪惠風(Huei-Fong Hung)
13:35
J-curve, Vascular Aging, and Calcium Channel Blockers…………………………陳震寰
(Chen-Huan Chen)
Chair: 謝宜璋(I-Chang Hsieh)
14:05
Clinical Discussion ……………………………………………………………………………. All
14:25
Closing Remarks……………………………………………………………陳志鴻
(Jyh-Hong Chen)
- 49 -
5月15日〈星期日〉13:00-14:30
SUNDAY, MAY 15, 2011
台北國際會議中心(TICC)
Room 201DE
SATELLITE SYMPOSIUM: PARADIGM CHANGE IN THROMBOSIS
MANAGEMENT
13:00
Opening Remarks………………………………………………………………………江正文
(Cheng-Wen Chiang)
Chair: 殷偉賢(Wei-Hsian Yin)
13:05
Trial Designs in AF-related Stroke: How do they Relate to
Real-world Practice……………………………………………………………………...江晨恩
(Chern-En Chiang)
Chair: 李啟明(Chii-Ming Lee)
13:35
Optimising Antithrombotic Therapy in Perioperative Management……………….吳造中
(Chau-Chung Wu)
Chair: 駱惠銘 (Huey-Ming Lo)
14:05
Panel Discussion ……………………………………………………………………………All
14:25
Closing Remarks………………………………………………………………………….陳志鴻
(Jyh-Hong Chen)
- 50 -
5月15日〈星期日〉13:00-14:30
SUNDAY, MAY 15, 2011
台北國際會議中心(TICC)
Room 201A
SATELLITE SYMPOSIUM: PULMONARY ARTERIAL HYPERTENSION
13:00
Opening Remarks ………………………………………………………………………..洪瑞松
(Jui-Sung Hung)
Chair: 洪瑞松(Jui-Sung Hung)
13:05
Challenges We Face to Treat PAH……………………………………………………王國陽
(Kuo-Yang Wang)
Chair: 許子秀(Tsu-Shiu Hsu)
13:30
Case Report-1…………………………………………………………………………….賴超倫
(Chao-Lun Lai)
Chair: 常敏之(Tsu-Shiu Hsu)
13:50
Case Report-2……………………………………………………………………………鄭錦昌
(Jin-Chang Cheng)
Chair: 傅懋洋(Morgan Mao-Young Fu)
14:10
Panel Discussion ……………………………………………………………………………….All
14:25
Closing Remarks…………………………………………………………………………曾春典
(Chuen-Den Tseng)
- 51 -
5月15日〈星期日〉13:00-14:30
SUNDAY, MAY 15, 2011
台北國際會議中心(TICC)
Room 201F
SATELLITE SYMPOSIUM: OVERCOMING BARRIERS TO GLYCEMIC
CONTROL IN 21TH CENTURY: WHERE SHOULD WE NEED TO BE?
13:00
Opening Remarks………………………………………………………………………蔡良敏
(Liang-Miin Tsai)
Chair: 林俊立(Jiunn-Lee Lin)
13:05
Examining Hypoglycemia and Understanding the Risks: Special
Considerations for Diabetic CVD Patients………………………………………...….曾慶孝
(Ching-Hsiao Tseng)
Chair: 劉俊鵬(Chun-Peng Liu)
13:30
Confronting Obstacles to Glycemic Control: The Role of
DPP-4 Inhibitors and Current Consensus…………………………………………….杜思德
(Shih-Te Tu)
Chair: 侯嘉殷(Charles Jia-Yin Hou)
13:55
Panel Discussion………………………………………………………………………………..All
14:25
Closing Remarks…………………………………………………………………………吳德朗
(Delon Wu)
- 52 -
5月15日〈星期日〉14:30-17:30
SUNDAY, MAY 15, 2011
台北國際會議中心(TICC)
Room 201BC
POST ACC HIGHLIGHT SYMPOSIUM
14:30
Opening Remarks………………………………………………………………………陳志鴻
(Jyh-Hong Chen)
Chair: 黃世忠(Shih-Chung Huang)
14:35
Hypertension………………………………………………………………………………曾炳憲
(Bing-Hsiean Tzeng)
Chair: 程文俊(Wen-Jin Cherng)
14:55
Cardiac Function and Heart Failure……………………………………………………殷偉賢
(Wei-Hsian Yin)
Chair: 溫明賢(Ming-Shien Wen)
15:15
Cardiac Arrhythmia ─ New 2011 ACC/AHA/ESC Guidelines for AF…………江晨恩
(Chern-En Chiang )
Chair: 葉森洲(San-Jou Yeh)
15:35
Prevention and Lipids……………………………………………………………………許百豐
(Pai-Feng Hsu)
Chair: 葉宏一(Hung-I Yeh)
15:55
Basic Research………………………………………………………………………….張釗監
(Chao-Chien Chang)
Chair: 林幸榮(Shing-Jong Lin)
16:15
Cardiac Vascular Interventions ─ PARTNER, PRECOMBAT, EVERESTII,
ISAR-CABG STICH, RIVA Trials……………………………………………………….劉如濟
(Ju-Chi Liu)
Chair: 林中生(Chung-Sheng Lin)
16:35
Pulmonary Artery Hypertension………………………………………………………..賴超倫
(Chao-Lun Lai)
Chair: 程俊傑(Jun-Jack Cheng)
16:50
Image and Diagnostic Testing ─ DEMEDIAL II Trial…………………………..莊文博
(Wen-Po Chuang)
Chair: 江福田(Fu-Tien Chiang)
17:05
Late Breaking Trials ─ OSCAR, NAGORA HEART PROTECT ZON-AMI IIb,
EXCELLECT, STICH Trials……………………………………………………………..江晨恩
(Chern-En Chiang)
17:25
Closing Remarks………………………………………………………………………….李源德
(Yuan-Teh Lee)
- 53 -
5月15日〈星期日〉14:30-16:00
SUNDAY, MAY 15, 2011
台北國際會議中心(TICC)
Room 201DE
CARDIAC-REHABILITATION
Chairs: 林中生(Chung-Sheng Lin)、王國陽(Kuo-Yang Wang)
14:30
15:00
15:30
Recent Advances in Exercise and Cardiac Rehabilitation…………………………陳思遠
( Ssu-Yuan Chen )
The Application of Tai Chi Chuan in Cardiac Rehabilitation………………………藍 青
( Chih Lan )
Effects of Hypoxic Exercise on Cardiac, Muscular and Cerebral
Hemodynimics…………………………………………………………………………….王鐘賢
(Jong-Shyan Wang )
- 54 -
5月15日〈星期日〉14:30-17:30
SUNDAY, MAY 15, 2011
台北國際會議中心(TICC)
Room 102
人體試驗講習班(IRB)
14:20
Opening Remarks………………………………………………………………………...雷孟桓
(Meng-Huan Lei)
Chair: 陳肇文(Jaw-Wen Chen)
14:30
研究人員對人體試驗委員會應有的認識（介紹審查流程、
修正案申請、SAE 通報、結案等）……………………………………………陳祖裕
(Cho-Yu Chan)
15:15
IRB 對基因及生物標記研究的審查………………………………………………陳祖裕
(Cho-Yu Chan)
16:00
藥品優良臨床試驗準則(GCP)……………………………………………………林志六
(Chih-Liu Lin)
16:45
人體試驗管理辦法及基因生物標記相關法規之介紹……………………林志六
(Chih-Liu Lin)
17:20
綜合討論及回饋評估………………………………………………………………陳肇文
(Jaw-Wen Chen)
- 55 -
5月15日〈星期日〉14:00-17:30
SUNDAY, MAY 15, 2011
台北國際會議中心(TICC)
Room 103
LABORATORY SKILL WORKSHOP
研究工作坊
【課程一】
主
題：血液內皮起源細胞之收集與功能測試
籌 劃 人: 葉宏一 (Hung-I Yeh)
時
間：14:00-15:30PM
參加人數：20 人。(需事先報名，不開放現場報名參與)
【課程二】
主
題：DNA 萃取及基因型
課程籌劃人: 柯毓麟 (Yu-Lin Ko)
時
間：16:00-17:30PM
參加人數：20 人。(需事先報名，不開放現場報名參與)
- 56 -
5月14日〈星期六〉10:00-10:30
SATURDAY, MAY 14, 2011
海報獎競賽區
Chaired Posters: P1-01 ~ P1-06
Chairs:張念中(Nen-Chung Chang)、李貽恆(Yi-Heng Li)、吳懿哲(Yih-Jer Wu)
P1-01
NOS1AP Variant Potentiates Methadone-Associated QTc Prolongation in
Han Chinese Men During Treatment for Heroin Dependence……………………張坤正
(Kuan-Cheng Chang)
P1-02
The Mechanical Properties of Carotid Artery Accessed by Speckle
Tracking were Associated with Arterial Stiffness and Heart Failure……………...廖若男
(JN Liao)
P1-03
Intragraft Pressure-guided Technique Reduces the Number of Angiograms,
Procedural Times and Arterial Embolism Compared With Angiography-guided
Technique in Salvage of Thrombosed Hemodialysis Grafts: A Comparative
Study……………………………………………………………………………………….劉開璽
(Kai-Hsi Liu)
P1-04
The Pharmacogenetic Effects of Angiotensin-converting Enzyme Inhibitors on
Long-term Prognosis of Coronary Artery Disease in a Large Angiographic
Population: A 12-year Follow-up Study…………………………………………….....吳卓鍇
(Cho-Kai Wu)
P1-05
The Role of Protease-activated Receptor 2 in Lipopolysaccharide-induced
Inflammatory Effects in Human Vascular Endothelial Cells………………………..陳錦澤
(Jin-Jer Chen)
P1-06
Unique Risk Factors of Myocardial Infarction in the Taiwanese General
Population…………………………………………………………………………………張勝南
(Sheng-Nan Chang)
- 57 -
5月14日〈星期六〉15:30-16:00
SATURDAY, MAY 14, 2011
海報獎競賽區
Chaired Posters: P2-01 ~ P2-06
Chairs: 徐國基(Kou-Gi Shyu)、TAB ( )、TAB ( )
P2-01
Wave Reflection but Not Arterial Stiffness is Much Highly Correlated with
24 Hours Ambulatory Blood Pressure Parameters Include Blood Pressure
Variability and Morning Blood Pressure Surge………………………………………許百豐
(Pai-Feng Hsu)
P2-02
Percutaneous Coronary Intervention Reduces In-hospital Mortality in
Elderly Patients after Acute Myocardial Infarction— A Nationwide Analysis
of 62,576 Patients in Taiwan During 2003-2008…………………………………….謝棟漢
(Tung-Han Hsieh)
P2-03
Senescence Disturbs the Network Structure and Functional Integrity of
Mitochondria in Human Endothelial Progenitor Cells……………………………….王學孝
(Hsueh-Hsiao Wang)
P2-04
Differential Response of Post-Exercise Regional Systolic Myocardial
Accommodation to Aldosterone Antagonism in Diastolic Failing Heart was
Based on the Presence of Ventricular Dyssynchrony………………………………李建霖
(Chien-Lin Lee)
P2-05
Carotid Artery Stenting Improves Neurocognitive Function Only in Severe
Internal Carotid Occlusive Disease with Objective Cerebral Ischemia………… ..林茂欣
(Mao-Shin Lin)
P2-06
Characteristics and Outcomes of Atypical Presentations in Patients with
Acute Coronary Syndrome………………………………………………………………張瑋婷
(Wei-Ting Chang)
- 58 -
5月14日〈星期六〉08:30-17:00
SATURDAY, MAY 14, 2011
1F, 海報展示區
POSTER PRESENTATION ( I )
CARDIAC IMAGING
P1-07
The Influence of Mitral Valve Regurgitation on Left Atrial Volume………………林斯晨
(Sir-Chen Lin)
P1-08
Can Carotid Plaque and Intima-media Thickness Predict Patient with
Documented Coronary Artery Disease?………………………………………………李兆程
(Jaw-Chen Lee)
P1-09
Preclinical Reduction of Diastolic Deformation in Fabry Disease by
Strain Echocardiography………………………………………………………………..張詩聖
(Shih-Sheng Chang)
P1-10
Value of Magnetocardiography in For Noninvasive Detection of Cardiac
Allograft Vasculopathy…………………………………………………………………..吳彥雯
(Yen-Wen Wu)
P1-11
Impact of Coronary Calcification on the Diagnostic Accuracy of
Multidetector Computed Tomography for Detecting Coronary Artery Disease….劉怡凡
(I-Fan Liu)
P1-12
Pseudo-lesion Over Right Superficial Femoral Artery And Right Popliteal
Artery Identified By Leg 3-D Angiography…………………………………………….徐中和
(Chung-Ho Hsu)
P1-13
Unruptured Aneurysm of Ascending Aorta with Aortic Valve Regurgitation
complicated with Acute Myocardial Infarction………………………………………廖振宇
(Zhen-Yu Liao)
P1-14
Increased Left Ventricular Torsion in Patients with Mechanical Ventilation by
Vector Velocity Imaging…………………………………………………………………陳坤雄
(Kwen-Hsiung Chen)
P1-15
The Effect Of Thrombolytic Therapy With Urokinase Assisted Percutaneous
Transluminal Angioplasty In The Management For Thrombosed Hemodialysis
Vascular Access: Yilan Experience……………………………………………………許育誠
(Yu-Cheng Hsu)
- 59 -
P1-16
The Relationship between Daily Alcohol Intake, Electrocardiographic
Manifestations and Ventricular Geometries from a Community
Drawn Population…………………………………………………………………………祁栢慶
(Po-Ching Chi)
P1-17
Isolated Interventricular Septal Diverticulum Presented as Unstable Angina–
A Case Report…………………………………………………………………………….黃友君
(You-Chun Huang)
P1-18
Morphologic Description and Quantification of Left Main Coronary Artery
Lesions by Real-Time Trans-esophageal Echocardiography……………………...劉俊傑
(Chun-Chieh Liu)
HYPERTENSION
P1-19
Vascular Aging and Orthostatic Hypotension………………………………………曾梓維
(Tzu-Wei Tseng)
P1-20
Effects of Anti-hypertensive Agents on Arterial Stiffness, Central
Hemodynamics and Ventriculo-Arterial Coupling: A Comparison
Between Monotherapy with Angiotensin Receptor Blocker and Calcium
Channel Blocker…………………………………………………………………………..林恆旭
(Heng-Hsu Lin)
P1-21
Thiazide Diuretics in Nondiabetic Essential Hypertension with and without
Metabolic Syndrome……………………………………………………………………..黃金洲
(Chin-Chou Huang)
P1-22
Predictors of the Long-term Outcomes in Patients with Secondary
Hypertension………………………………………………………………………………邱淳志
(Chun-Chih Chiu)
P1-23
Decreased Circulating Endothelial Progenitor Cell Levels and Function in
Essential Hypertensive Patients with Electrocardiographic Left Ventricular
Hypertrophy……………………………………………………………………………….李慶威
(Ching-Wei Lee)
P1-24
Redefine the Diagnostic Usage of Second Systolic Peak of Peripheral
Pulse Wave………………………………………………………………………………..林美每
(Mei-Mei Linb)
P1-25
Association between Metabolic Syndrome and Electrographic Left Ventricular
Hypertrophy in Hypertension Patients…………………………………………………李文賢
(Wen-Hsien Lee)
- 60 -
BASIC SCIENCE
P1-26
Enhanced Endothelial Differentiation of Endothelial Progenitor Cells
with Cilostazol and Effect of Combined Cell Therapy with Cilostazol
in Murine Hindlimb Ischemia……………………………………………………………趙庭興
(Ting-Hsing Chao)
P1-27
Resveratrol Protects Left Ventricle by Increasing Adenylate Kinase 1
and Isocitrate Dehydrogenase in Rats with Myocardial Infarction………………..林正豐
(Jeng-Feng Lin)
P1-28
Urotensin II Prevents Doxorubicin-induced Cardiomyocyte Apoptosis…………陳錦澤
(Jin-Jer Chen)
P1-29
A Novel Role of Sesamol in Inhibiting NF-κB-mediated Signaling in
Platelet Activation………………………………………………………………………..張釗監
(Chao-Chien Chang)
P1-30
Placenta-Derived Multipotent Cells in Cardiac Repair……………………………劉芫宏
(Yuan-Hung Liu)
P1-31
An Animal Model of Assessing Mouse Hind Limb Endothelial Function
by Measuring……………………………………………………………………………...陳士仁
(Shih-Jen Chen)
P1-32
Niacin Improves Ischemia-induced Neovascularization by Enhancement
of Endothelial Progenitor Cell Functions in Diabetic Mice…………………………黃柏勳
(Po-Hsun Huang)
P1-33
The Role of Transient Receptor Potential Vanilloid Channels in Hypoxic
Preconditioning-Mediated Cardioprotection in Rats…………………………………王致皓
(Chih-Hao Wang)
P1-34
Inhibition of Nitric Oxide Synthase Normalizes Force-and velocity-dependent
Indices of Cardiac Contractility in Diabetic Rats: Roles of Nitrosative Stress
and Myosin Heavy Chain Proteolysis and Isoform Switch…………………………葉東峰
(Dong-Feng Yeih)
P1-35
Homocysteine Up-regulates Cyclooxygenase-2 Expression in Human
Mononuclear Cells………………………………………………………………………..宋茂林
(Mao-Lin Sung)
- 61 -
P1-36
High Glucose Concentrations Induce Bone Loss via Attenuating the
Proliferation and Osteoblastogenesis and Enhancing Adipogenesis of
Mesenchymal Stem Cells Derived from Rat Bone Marrow…………………………何豐名
(Feng-Ming Ho)
P1-37
The Role of Heme Oxygenase-1 in the Hypoxia/reoxygenation-induced
Inflammatory Status of Human Umbilical Vein Endothelial Cells………………….趙嘉倫
(Chia-Lun Chao)
P1-38
The Atherogenic LDL-L5 Can be Induced by High Cholesterol Diet and
Ameliorated by Ezetimibe in Hamsters－An Innovative Animal Model for
Atherosclerosis Research……………………………………………………………….楊子慶
(Tzu-Ching Yang)
P1-39
The Role of Direct Rennin Inhibitor on the Expression of Vascular Matrix
Metalloproteinases in the Hypercholesterolemia-denuded Animal Model……….吳道正
(Tao-Cheng Wu)
P1-40
Adipose-Derived Mesenchymal Stem Cell Protects Kidneys against
Ischemia-Reperfusion Injury through Suppressing Oxidative Stress and
Inflammatory Reaction…………………………………………………………………..陳永隆
(Yung-Lung Chen)
P1-41
Autologous Transplantation of Adipose-Derived Mesenchymal Stem
Cells Markedly Reduced Acute Ischemia-Reperfusion Lung Injury in
a Rodent Model…………………………………………………………………………...黃民評
(Min-Ping Huamng)
P1-42
An Animal Model of Assessing Mouse Hind Limb Endothelial Function by
Measuring Femoral Artery Blood Flow Responses………………………………….陳士仁
(Shih-Jen Chen)
GENERAL CARDIOLOGY
P1-43
Constrictive Pericarditis in A Patient with Normal Pericardial Thickness………..吳靜芬
(Ching-Fen Wu)
P1-44
Improving Quality of Life in Symptomatic Patients with Infra -popliteal
Diffuse Peripheral Obstructive Disease by Intermittent Pneumatic
Compression Therapy……………………………………………………………………張士泰
(Shih-Tai Chang)
P1-45
Coronary Artery Disease by Three Metabolic Syndrome Definitions……………張容容
(Jung-Jung Chang)
- 62 -
P1-46
Renal Infarction in a Atrial Fibrillation Patient: A Case Report……………………邱昱偉
(Yu-Wei Chiu)
P1-47
Comparison between a New Tool “eTRACKING” and Brachial-ankle
Pulse Wave Velocity for the Evaluation of Arterial Stiffness………………………蔡忠文
(Chung-Wen Tsai)
P1-48
Successful Endovascular Treatment of Chronic Infra-renal Aortic Occlusion…許榮城
(Jung-Cheng Hsu)
P1-49
The Increasing Prevalence of Peripheral Artery Occlusive Disease in
Hemodialysis Patients : A 2-year Follow Up………………………………………….蘇河名
(Ho-Ming Su)
P1-50
Painless Aortic Dissection Presenting as Syncope: A Case Report and
Review of the Literature…………………………………………………………………蔡維哲
(Wei-Che Tsai)
P1-51
Symptomatic Bradycardia as a First Sign of Coronary Heart Disease－
Analysis of Three Cases………………………………………………………………...曾聖雄
(Sheng-Shiung Tzeng)
P1-52
Tuberculous Pericarditis Complicated with Cardiac Temonade –
A Case Report and Literature Review…………………………………………………崔東霖
(Tung-Lin Tsui)
P1-53
Predictors of Mortality and Malignant Ventricular Arrhythmias in
Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia…………………….鐘法博
(Fa-Po Chung)
P1-54
Takotzubo Cardiomyopathy Associated with Influenza A (H1N1) Infection……王子林
(Tzu-Lin Wang)
P1-55
Acute Pulmonary Embolism in a Male with Antithrombin III Deficiency
Successfully Treated by Lifelong Nnticoagulant Therapy OnlyA Case Report…………………………………………………………………………….杜宗明
(Chung-Ming Tu)
P1-56
The Relationship between Body Size, Fat Composition, Serum
Creatine Kinase(CK) Level and Vascular Function in Healthy People………...…顏志軒
(Chih-Hsuan Yen)
- 63 -
P1-57
Major Adverse Cardiovascular Events and Mortality in Peripartum
Lupus Patients…………………………………………………………………………….巫龍昇
(Lung-Sheng Wu)
P1-58
Single Nucleotide Polymorphisms of Arginine Vasopressin Receptors in
Patients with Severe Sepsis and Septic Shock………………………………………趙家鼎
(Chia-Ting Chao)
P1-59
Immediate and Mid-term Outcomes of Excimer Laser Angioplasty for
Complex Femoropopliteal Arterial Occlusive Disease………………………………黃玄禮
(Hsuan-Li Huang)
P1-60
The Long-term Follow-up of Anomalous Coronary Arteries Incidence and
Clinical Outcomes in Patients Undergoing Coronary Angiography……………….張鴻猷
(Hung-Yu Chang)
P1-61
Association between Herpes Simplex Virus Infection and Increased Risk
of Atrial Fibrillation: A Nationwide Study……………………………………………...江佳鴻
(Chia-Hung Chiang)
P1-62
Gout and Atrial Fibrillation— A Nationwide Population-based Study…………….洪培倫
(Pei-Lun Hung)
P1-63
Predictors of Lower Extremity Amputation or Revascularization in Patients
with Peripheral Artery Diseases– A Population-Based Investigation…………….陳建鈞
(Jien-Jiun Chen)
P1-64
Different Impacts of Body Fat Composition on Left Ventricular Mass
and Geometric Alterations………………………………………………………………賴堯暉
(Yau-Huei Lai)
P1-65
Serum miRNAs in Acute Myocardial Infarction………………………………………褚柏顯
(Pao-Hsien Chu)
P1-66
High-sensitive C-reactive Protein Level as a Predictor of New-onset
Diabetes Mellitus in the Hypertensives with Impairing Fasting Glucose…………許栢超
(Po-Chao Hsu)
P1-67
High-sensitive C-reactive Protein Level as a Predictor of New-onset Chronic
Kidney Disease in the Hypertensives………………………………………………….朱俊源
(Chun Yuan Chu)
P1-68
Right Ventricular Compression in Aortic Dissection………………………………...陳昇遠
(Sheng-Yuan Chen)
- 64 -
P1-69
Primary Stenting for Acute Ischemic Stroke: Single Center Experience………… 羅顯榮
(Hin-Wing Law)
P1-70
Successful PTA in a Case with CTO of RSFA and CTO of Right
Infra-geniculate Arteries…………………………………………………………………徐中和
(Chung-Ho Hsu)
- 65 -
5月15日〈星期日〉08:30-17:00
SUNDAY, MAY 15, 2011
1F, 海報展示區
POSTER PRESENTATION ( II )
ELECTROPHYSIOLOGY
P2-07
Carotid Artery Stenting Improves Autonomic Function Most in
Carotid-occluded Patients through Neuro-cardiac Regulation…………………….李任光
(Jen-Kuang Lee)
P2-08
Associations Between the CHADS2 Score, Atrial Substrate Properties
And Outcome of Catheter Ablation in the Patients with Paroxysmal
Atrial Fibrillation…………………………………………………………………………..趙子凡
(Tze-Fan Chao)
P2-09
Longitudinal Change of Electrophysiological Characteristics in Patients
with Sick Sinus Syndrome………………………………………………………………黃嵩豪
(Sung-Hao Huang)
P2-10
Catheter Ablation of Atrial Fibrillation Initiating from Superior Vena Cava:
Long-Term Follow-up Result……………………………………………………………張鴻猷
(Hung-Yu Chang)
P2-11
Discrepancy of Right Ventricular Endocardial Scar and the Right
Ventricular Function in Patients with Right Ventricular Outflow Tract
Tachycardia－A Novel Finding…….…………………………………………………..李政鴻
(Cheng-Hung Li)
P2-12
Clinical Outcomes Of Implantable Cardiac defibrillator: Results From the
Analysis Of 239 Patients Registry……………………………………………………..賴志泓
(Jr-Hong Lai)
P2-13
Clinical Outcomes of Patients with Symptomatic Bradyarrhythmias Requiring
Temporary Pacemakers, and the Predictors for Short-term and Long-term P
ermanent Pacemakers Implants………………………………………………………..周玉蘭
(Yu-Lan Jou)
P2-14
Can Revasculization Prevent Permanent Pacemaker Implants in Patients
Suffering from Significant Bradyarrhythmias Complicating Acute Coronary
Syndrome………………………………………………………………………………….周玉蘭
(Yu-Lan Jou)
- 66 -
P2-15
A Case of Arrhythmogenic Right Ventricular Cardiomyopathy: ICD
Implantation and Long-time Follow up………………………………………………...邱威智
(Wei-Chih Chiu)
P2-16
Catheter Ablation of Atrial Tachyarrhythmia in Patients with Prior Valvular
Surgery…………………………………………………………………………………….張鴻猷
(Hung-Yu Chang)
PEDIATRIC CARDIOLOGY
P2-17
Association of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1)
Gene Polymorphism and Kawasaki Disease…………………………………………翁根本
(Ken-Pen Weng)
P2-18
Mid-term outcome After Repair of Tetralogy of Fallot With Absent
Pulmonary Valve………………………………………………………………………….陳孟妤
(Meng-Yu Chen)
CARDIOVASCULAR SURGERY
P2-19
Reversal of Flow in the Mammary Artery to Treat Subclavian Steal
Syndrome in Conjunction with Coronary Bypass and Valvular Surgery………… .賀業宏
(Yeh-Hong Ho)
P2-20
Right Ventricular Tumor－A Rare Case Report…………………..…………………黃懷緒
(Huai-Hsu Huang)
P2-21
Surgical Treatment for Late Infection of Abdominal Aortic Endograft:
A Case Report…………………………………………………………………………….方副吉
(Fu-Chi Fang)
P2-22
Catheter-directed Thrombolysis with Urokinase for the Treatment of
Acute Lower Extremity Arterial Thrombosis in a Patient……………………………李志賢
(Chih-Hsien Lee)
P2-23
Synchronous Carotid Artery Stenting and Open Heart Surgery Follow by
Thoracic Endovascular Aneurysm Repair: A Case Report…………………………呂志明
(Chee-Meng Lee)
P2-24
Penetrating Atherosclerotic Ulcers (PAUs) and Other Ulcer-like Lesions
of the Aorta: What the Hell was That?………………………………………………...甘宗本
(Chung-Ben Kan)
- 67 -
P2-25
Catheter-Directed Thrombolysis with Adjunct Therapy in Treatment of
Deep Lower Limbs Venous Thrombosis………………………………………………魏日華
(Jih-Hua Wei)
CORONARY ARTERY DISEASE
P2-26
Cerebral Hemorrhage Caused by Dual Anti-platelet Therapy after Peripheral
Arterial Thrombus was Aspirated in Patient with Atrial Fibrillation……………….刘海涛
(Hai-Tao Liu)
P2-27
Circulating Adipocyte Fatty Acid-Binding Protein in Patients at High Risk
for Coronary Artery Disease…………………………………………………………….黃啟倫
(Chi-Lun Huang)
P2-28
Multiple-biomarkers Assessment offers Additive Risk Prediction in Patients
with Acute Coronary Syndrome………………………………………………………...李任光
(Jen-Kuang Lee)
P2-29
Using Cardiovascular Risk Scores to Predict Plaque Severity in
Asymptomatic Low- to intermediate-risk Subjects…………………………………..李百卿
(Bai-Chin Lee)
P2-30
Technique of Percutaneous Coronary Intervention for Anomalous Origin
of the Right Coronary Artery……………………………………………………………林俊忠
(Chun-Chung Lin)
P2-31
Lower Oxidized LDL Autoantibodies Predict Restenosis in Acute
Myocardial Infarction Patient after Primary Balloon Angioplasty………………… .黃靜惠
(Ching-Hui Huang)
P2-32
Factors Affecting the Maintenance Dose of Warfarin in Hospitalized Patients…黃獻民
(Shiann-Min Huang)
P2-33
Special Considerations for the Use of Endothelial Progenitor Cell-Capturing
Stents in Selected Patients- A Single Center Experience………………………….邱俊仁
(Chiung-Zuan Chiu)
P2-34
Percutaneous Treatment of Challenging Subclavian Arterial Lesions via
Brachial Access…………………………………………………………………………..林俊呈
(Jiunn-Cherng Lin)
P2-35
A 6-year Follow-up of Sirolimus-eluting Stents versus Paclitaxel-eluting
Stents Results in an Asian Population- A Single Center Experience in Taiwan..謝慕揚
(Mu-Yang Hsieh)
- 68 -
P2-36
The Experience of Routine Fractional Flow Reserve Assessment to
Determine the Need for Angioplasty in Shin Kong Hospital (SKH)……………….魏丞駿
(Cheng-Chun Wei)
P2-37
Long-term Clinical Outcomes of Second-Generation Zotarolimus- eluting
Stent in Taiwanese People – A Single Center Experience…………………………邱俊仁
(Chiung-Zuan Chiu)
P2-38
Percutaneous Treatment of an Acute Mesenteric Ischemia Induced
Peritonitis: A case Report……………………………………………………………….莊銘仁
(Ming-Jen chuang)
P2-39
The Association of Tooth Scaling and Decreased Cardiovascular
Disease－A Nationwide Population-based Study…………………………………..陳思穎
(Zu-Yin Chen)
P2-40
Incidence and Predictors of Contrast Induced Nephrology after Coronary
Intervention for Chronic Total Occlusion Lesions: Single Center Experience…..林祐賸
(Yu-Sheng Lin)
P2-41
Using Modified Moving Analysis of T-wave Alternans to Predict
Multivessel and High Risk Coronary Artery Disease in Patients with
Chronic Stable Angina…………………………………………………………………..莊俊斌
(Chun-Pin Chuang)
P2-42
Prognostic Role of the New Highly Sensitive Cardiac Troponin T in Patients
with Acute Coronary Syndrome– the First Taiwan Experience……………………李任光
(Jen-Kuang Lee)
P2-43
Angiographic and Clinical Results for Chronic Total occlusion Lesions－
Comparing with Drug Eluting Stent and Bare metal Sten………………………….于慶龍
(Ching-Lung Yu)
P2-44
Drug Eluting Stents and Bare Metal Stents in Patients with Diabetes……………吳柏青
(Po-Ching Wu)
P2-45
Bead-like Coronary Spasm……………………………………………………………曾聖雄
(Sheng-Shiung Tzeng)
P2-46
Incorporation of Balloon-cushion Stenting Technique in Left Main
Coronary Artery Bifurcation PCI………………………………………………………..顧博明
(Po-Ming Ku)
- 69 -
P2-47
Predictors of Clinic Outcome of Percutaneous Coronary Intervention for
Cardiac Allograft Vasculopathy…………………………………………………………曾今坤
(Chin-Kun Tseng)
P2-48
The Safety and Feasibility of Sheathless Transradial Carotid Artery Stenting… .方修御
(Hsiu-Yu Fang)
P2-49
Very Late Bare Metal Stent Thrombosis Presenting with Acute Myocardial
Infarction: 9 Years after Coronary Stenting ………………………………………….林美每
(Mei-Mei Lin)
P2-50
Outcomes of Patients with Killip Class III Acute Myocardial Infarction after
Primary Percutaneous Coronary Intervention ……………………………………….蔡子賢
(Tzu-Hsieng Tsai)
P2-51
Outcomes of Patients Undergoing Immediate/Primary PCI for
Non-ST-Elevation and ST-Elevation Myocardial Infarction………………………...林俊元
(Chun-Yuan Lin)
P2-52
Clinical Application of StentBoost Imaging Technology in Percutaneous
Coronary Intervention……………………………………………………………………雷孟桓
(Meng-Huan Lei)
P2-53
Feasibility of Transulnar Coronary Catheterization in Patients with
Limitation of Utilizing Radial Arterial Route…………………………………………..薛書凱
(Shu-Kai Hsueh)
P2-54
Randomized Study of Comparison between Conventional Coronary
Angiography and Rotational One Concerning Contrast Utilization,
Fluoroscopic Time and Procedure Time………………………………………………尤和平
(Ho-Ping Yu)
P2-55
The Current state and analysis of CTO management in Taitung
Area A Single Hospital Experience…………………………………………………….王光德
(Kuang-Te Wang)
P2-56
GRACE Scoring System is Better than TIMI Scoring System in Risk
Stratification of Patients with Non-ST-segment Elevation
Myocardial Infarction…………………………………………………………………….陳昇遠
(Sheng-Yuan Chen)
- 70 -
HEART FAILURE
P2-57
Subclinical Systolic Dysfunction Detected in Asymptomatic Subjects
with Early Stage Atherosclerosis……………………………………………………….廖振宇
(Zhen-Yu Liao)
P2-58
High Inflammatory Response in Burned Patients Contributes to Cardiac
Diastolic Heart Failure through Slower Calcium Release…………………………..李任光
(Jen-Kuang Lee)
P2-59
Cardiac Resynchronization Therapy for Drug Refractory Heart FailureOne Center Experience………………………………………………………………….曾聖雄
(Sheng-Shiung Tzeng)
P2-60
Successful Treatment of Acute Coronary Syndrome Associatd with
Severe Sepsis Guided by Cardiac Index Monitor……………………………………崔東霖
(Tung-Lin Tsui)
P2-61
Prolonged Door-to-Balloon Time Correlates with In-hospital Diastolic
Dysfunction in Acute ST-Elevation Myocardial Infarction Patients
Undergoing Primary Percutaneous Coronary Intervention…………………………王宇澄
(Yu-Chen Wang)
P2-62
The Effect of Aliskiren on Endothelial Activation in Patients with Chronic
Heart Failure………………………………………………………………………………任勗龍
(Hsu-Lung Jen)
P2-63
Does Adiponectin Modulate the Recovery of Pulsatile Hemodynamics and
Clinical Outcomes in Acute Heart Failure Syndrome?……………………………...宋思賢
(Shih-Hsien Sung)
P2-64
Difference in Pulsatile Hemodynamics between Heart Failure with Normal
Left Ventricular Systolic Function and Systolic Heart Failure……………………..廖照峰
(Chao-Feng Liao)
P2-65
Reversible Reverse Remodeling in a Patient with Cardiac
Resynchronization Therapy……………………………………………………………..譚昭文
(Chao-Wen Tan)
P2-66
ScVO2- Facilitated the Weaning Process of Intra-aortic Balloon Pump in
Myocardial Infarction-related Acute Heart Failure…………………………………..辛和宗
(Ho-Tsung Hsin)
- 71 -
P2-67
Ventricular-Arterial Stiffness, Carotid Artery Remodeling and Systemic
Inflammation in Heart Failure with Preserved Ejection Fraction (HFpEF):
Possible Mechanism in the Transition from Hypertension to Heart Failure……..洪崇烈
(Chung-Lieh Hung)
- 72 -